{"pmid":32339717,"title":"Pulmonary thromboembolism in criticall ill COVID-19 patients.","text":["Pulmonary thromboembolism in criticall ill COVID-19 patients.","Int J Infect Dis","Scialpi, Michele","Scialp, Sara","Piscioli, Irene","Scalera, Giovanni","Longo, Fernando","32339717"],"journal":"Int J Infect Dis","authors":["Scialpi, Michele","Scialp, Sara","Piscioli, Irene","Scalera, Giovanni","Longo, Fernando"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339717","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ijid.2020.04.056","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665264685515014144,"score":8.574329,"similar":[{"pmid":32331965,"title":"Diagnosing Pulmonary Thromboembolism in COVID-19: A Stepwise Clinical and Imaging Approach.","text":["Diagnosing Pulmonary Thromboembolism in COVID-19: A Stepwise Clinical and Imaging Approach.","Acad Radiol","Rouhezamin, Mohammad Reza","Haseli, Sara","32331965"],"journal":"Acad Radiol","authors":["Rouhezamin, Mohammad Reza","Haseli, Sara"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331965","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.acra.2020.04.023","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1665071049707880448,"score":74.15394},{"pmid":32311843,"title":"Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.","text":["Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.","In March 2020, the global healthcare system is overwhelmed by patients infected with SARS-CoV-2, which is the cause of the coronavirus pandemic (Covid-2019). A large number of these patients end up in the intensive care units (ICU) with critical illness requiring mechanical ventilation. One of the most important clinical features of the infection is a profound coagulopathy. In a recent cohort study 71% of patients who eventually died matched the ISTH criteria for disseminated intravascular coagulation (DIC), while this percentage was only 0.6% in patients who survived.","Int J Lab Hematol","Beun, Robert","Kusadasi, Nuray","Sikma, Maaike","Westerink, Jan","Huisman, Albert","32311843"],"abstract":["In March 2020, the global healthcare system is overwhelmed by patients infected with SARS-CoV-2, which is the cause of the coronavirus pandemic (Covid-2019). A large number of these patients end up in the intensive care units (ICU) with critical illness requiring mechanical ventilation. One of the most important clinical features of the infection is a profound coagulopathy. In a recent cohort study 71% of patients who eventually died matched the ISTH criteria for disseminated intravascular coagulation (DIC), while this percentage was only 0.6% in patients who survived."],"journal":"Int J Lab Hematol","authors":["Beun, Robert","Kusadasi, Nuray","Sikma, Maaike","Westerink, Jan","Huisman, Albert"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311843","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ijlh.13230","source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1664632501441658881,"score":63.374405},{"pmid":32335420,"title":"Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.","text":["Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.","Thromb Res","Roncon, Loris","Zuin, Marco","Zonzin, Pietro","32335420"],"journal":"Thromb Res","authors":["Roncon, Loris","Zuin, Marco","Zonzin, Pietro"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335420","week":"202018|Apr 27 - May 03","doi":"10.1016/j.thromres.2020.04.021","keywords":["covid-19","d-dimer","venous thromboembolism"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665172301992165376,"score":62.006313},{"pmid":32305585,"title":"Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","text":["Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change.","J Vasc Surg Venous Lymphat Disord","Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K","32305585"],"abstract":["A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change."],"journal":"J Vasc Surg Venous Lymphat Disord","authors":["Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305585","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jvsv.2020.04.009","keywords":["anticoagulant","deep venous thrombosis","duplex ultrasound","pulmonary embolism","venous thromboembolism"],"source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1664641855752503296,"score":61.0534},{"pmid":32294289,"title":"Venous thromboembolism in COVID-19 patients.","text":["Venous thromboembolism in COVID-19 patients.","We read with interest the study published by Tang and coll.(1) in a recent issue of the Journal of Thrombosis and Haemostasis. In this retrospective analysis, conducted at the Tongji Hospital of Wuhan, China, it is reported that heparin treatment reduces mortality in subjects affected by severe COVID-19 who have \"sepsis-induced coagulopathy\". The definition of severe COVID-19 was the presence of at least one of following: respiratory rate >/=30 breaths /min; arterial oxygen saturation </=93% at rest; PaO2/FiO2 </=300 mmHg. The Authors of this study also reported that, among subjects not treated with heparin, mortality raised according with D-dimer levels. Of note, patients that received heparin in this study were mostly treated with enoxaparin, at the thromboprophylactic dose of 40-60 mg/day, for at least 7 days.","J Thromb Haemost","Porfidia, Angelo","Pola, Roberto","32294289"],"abstract":["We read with interest the study published by Tang and coll.(1) in a recent issue of the Journal of Thrombosis and Haemostasis. In this retrospective analysis, conducted at the Tongji Hospital of Wuhan, China, it is reported that heparin treatment reduces mortality in subjects affected by severe COVID-19 who have \"sepsis-induced coagulopathy\". The definition of severe COVID-19 was the presence of at least one of following: respiratory rate >/=30 breaths /min; arterial oxygen saturation </=93% at rest; PaO2/FiO2 </=300 mmHg. The Authors of this study also reported that, among subjects not treated with heparin, mortality raised according with D-dimer levels. Of note, patients that received heparin in this study were mostly treated with enoxaparin, at the thromboprophylactic dose of 40-60 mg/day, for at least 7 days."],"journal":"J Thromb Haemost","authors":["Porfidia, Angelo","Pola, Roberto"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294289","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jth.14842","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Enoxaparin","Heparin"],"_version_":1664636192702857216,"score":59.873817}]}